Centene reported a 5.9% year-over-year increase in second-quarter sales to $39.84 billion, beating the $36.46 billion consensus. Adjusted EPS rose to $2.42, surpassing the $2.07 consensus. Membership in the commercial marketplace grew, while Medicaid memberships declined.
Read more